No Data
No Data
NovelBeam Technology to Buy Back Shares of Up to 100 Million Yuan
Haitai Xinguang (688677.SH): Plans to spend 50 million to 0.1 billion yuan to repurchase shares.
On March 4, Gelonghui announced that Haitai Xinguang (688677.SH) stated that the shares repurchased this time are intended for implementing an employee stock ownership plan or Stock-based Incentive. The total amount of funds for the buyback will be no less than 50 million yuan (inclusive) and not exceed 100 million yuan (inclusive); the repurchase price per share will not exceed 59 yuan (inclusive). The funds for this buyback will come from the company's own resources and a special loan for Share Buyback. The company has obtained a "Loan Commitment Letter" from the Qingdao Branch of CM BANK, agreeing to provide special loan support for the company's share repurchase, with the maximum amount of the special loan not exceeding RMB.
Haitai Xinguang: Haitai Xinguang 2024 Annual Performance Report Announcement
Haitai Xinguang 2024 Annual Results Report Announcement
Haitai New Light (688677.SH): Net income of 0.135 billion yuan in 2024, a year-on-year decrease of 7.43%.
On February 25, Gelonghui reported that Haitai Xinguang (688677.SH) announced its 2024 annual performance report, with total revenue of 440.7026 million yuan, a year-on-year decrease of 6.35%, and a net income attributable to the parent company's owners of 134.8799 million yuan, down 7.43% year-on-year. 1. Affected by the inventory destocking of USA customers, the company's overseas revenue in the first three quarters declined significantly. Starting from the fourth quarter, customer inventory has dropped to a low level, and shipments have increased significantly compared to the same period in 2023. With the increase in customer demand, the company's overseas business revenue will further grow. 2. The company plans to promote its domestic complete machine business in 2024.
Haitai Xinguang (688677.SH): is planning to develop a surgical microscope product.
On February 17, Gelonghui reported that Haitai Xingguang (688677.SH) stated on the investor interaction platform that the company is planning to develop a surgical microscope product, but there is currently no timetable for its market launch.